AIP
ANTH

Ameritas Investment Partners’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Ameritas Investment Partners’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-346
Closed -$1K – 3102
2017
Q1 		$1K Buy
+346
New +$1.64K ﹤0.01% 2944

Other funds holding ANTH

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Ameritas Investment Partners's ANTH Position: Q2 2017 in Review

Ameritas Investment Partners sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2017, closing a stake of 346 shares — an estimated $1K sold.

Ameritas Investment Partners first reported a position in ANTH in Q1 2017 and held it in 1 quarter. The position peaked at $1K in Q1 2017. 40 funds tracked by Wall St. Rank hold ANTH as of Q2 2017.

  • Ameritas Investment Partners reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
  • Ameritas Investment Partners sold 346 Anthera Pharmaceuticals, Inc. shares in Q2 2017, an estimated $1K.
  • Ameritas Investment Partners first reported a position in Anthera Pharmaceuticals, Inc. in Q1 2017 and held it in 1 quarter.
  • Ameritas Investment Partners's Anthera Pharmaceuticals, Inc. position peaked at $1K in Q1 2017.
  • 40 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2017.

Based on Ameritas Investment Partners's 13F filing for Q2 2017, filed 15 Aug 2017.